-
Rebiotix Announces First Patient Enrolled in RBX2660 Phase 3 Clinical Trial
americanpharmaceuticalreview
August 08, 2017
Rebiotix has enrolled the first patient in a Phase 3 clinical trial of RBX2660 for the prevention of recurrent Clostridium difficile (C. diff) infection.RBX2660 is the first drug product in clinical study from the Microbiota Restoration Therapy (MRT) plat
-
Trial to identify breath biomarkers to improve the early detection and diagnosis of cancer
cphi-online
July 13, 2017
Owlstone Medical and Cancer Research UK initiate pan cancer clinical trial.
-
Microneedle patches for flu vaccination prove successful in first human clinical trial
europeanpharmaceuticalreview
July 03, 2017
Small skin patches with dissolvable microneedles were safe and well-tolerated, generated robust immunity against influenza, could be self-administered by study participants and were strongly preferred over shots.
-
Trovagene Submits Investigational NDA to Initiate Phase 1b/2 PCM-075 Clinical Trial for AML
pharmaceutical-technology
June 28, 2017
Trovagene announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to conduct a Phase 1b/2 clinical trial of PCM-075, their polo-like kinase 1 (PLK1) inhibitor for the treatment of patients w
-
New industry forum to advance clinical trial participation
europeanpharmaceuticalreview
June 20, 2017
In 2018, industry leaders from pharma, biotech and clinical research organisations will advance the participation of patients in clinical trials…
-
'Now, India has a balanced, scientific regulatory framework for clinical trials'
biospectrumasia
June 07, 2017
"With only 1.4% of global clinical trials in a country that has the highest disease burden in the world, we need to encourage more sponsors to conduct clinical research in India as well as create a strong eco system for indigenous innovation and R&D," say
-
Hovione Starts Phase 1 Clinical Trial of HY02
contractpharma
May 27, 2017
HY02 is a proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation
-
Recipharm Opens GMP Suite for Clinical Trial Materials
contractpharma
April 25, 2017
$750k investment will focus on non-sterile dosage forms including metered dose inhalers and semi-solid topical products
-
US FDA agrees to abridged clinical Phase III for Wockhardt’s WCK 5222
financialexpress
April 06, 2017
A combination of Zidebactam and Cefepime, WCK 5222 represents a new class of antibiotic treatment for AMR
-
Bad start to month for Karyopharm gets worse with clinical hold
pharmafile
March 14, 2017
Coming just over a week after Karyopharm Therapeutics had announced that its lead drug had failed in a Phase 2 trial to extend overall survival, it was also hit with a partial clinical trial hold on the same drug.